QURALIS
QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .
QURALIS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-12-12
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.quralis.com
Total Employee:
1+
Status:
Active
Contact:
(+1) 617.682.6015
Email Addresses:
[email protected]
Total Funding:
47.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Amplo Biotechnology
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Arbor Biotechnologies
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.
Biopalette
Biopalette is a operator of a platform intended to offer gene-editing techniques.
BridGene Biosciences
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
DeepBiome Therapeutics
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Goldfinch Biopharma
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
IDEAYA Biosciences
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
Illuminare Biotechnologies
Illuminare Biotechnologies is a operator of a biotechnology company intended to reduce risk of nerve damage during surgery.
Latigo Biotherapeutics
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.
Maze Therapeutics
Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Microbiotica
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.
Ncardia
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Semarion
Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.
Speratum
Speratum is a biotechnology company dedicated to research and development (R&D) of targeted molecular therapies for cancer treatment.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Viralytics
Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market
Current Advisors List
Current Employees Featured
Founder
Investors List
Mitsui Global Investment
Mitsui Global Investment investment in Series A - QurAlis
Sanford Biosciences
Sanford Biosciences investment in Series A - QurAlis
Droia Ventures
Droia Ventures investment in Series A - QurAlis
LS Polaris Innovation Fund
LS Polaris Innovation Fund investment in Series A - QurAlis
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series A - QurAlis
Inkef
Inkef investment in Series A - QurAlis
Mission BioCapital
Mission BioCapital investment in Series A - QurAlis
Dolby Family Ventures
Dolby Family Ventures investment in Series A - QurAlis
Amgen Ventures
Amgen Ventures investment in Series A - QurAlis
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - QurAlis
Official Site Inspections
http://www.quralis.com Semrush global rank: 3.71 M Semrush visits lastest month: 3.72 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "QurAlis"
QurAlis - Crunchbase Company Profile & Funding
QurAlis is a clinical-stage biotechnology company that is developing precision medicines with genetically validated targets for amyotrophic lateral sclerosis …See details»
Our Story - QurAlis
Our Story We now have an unprecedented deep understanding of the disease and the disease mechanisms which creates an opportunity to realize real treatment breakthroughs.See details»
People - QurAlis
Mar 12, 2025 Immediately prior to joining QurAlis, Robin was head of global patient safety at FibroGen, where she led a major initiative to drive an organizational modernization agenda in …See details»
Quiver Bioscience and QurAlis Announce Research Collaboration …
37 minutes ago CAMBRIDGE, Mass., May 15, 2025--Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X SyndromeSee details»
QurAlis Corporation - MassBio
QurAlis Corporation: Neuro Pioneers on a Quest to Cure At QurAlis, we consider ourselves “neuro pioneers” because we are driven to explore the deepest aspects of human neurology in order to find the treatments patients urgently need. We …See details»
QurAlis - EQT Group
Do You Want to Know More? We are eager to explore how we can achieve great things together.See details»
Quralis Corporation Company Profile | Cambridge, MA
Find company research, competitor information, contact details & financial data for Quralis Corporation of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
QurAlis Expands Leadership Team With Doug …
Jun 11, 2024 “QurAlis is a mission-driven organization dedicated to bringing transformative therapies to patients with ALS and other serious neurodegenerative diseases,” said Mr. Brown.See details»
QurAlis - VentureRadar
"QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes …See details»
QurAlis - LinkedIn
QurAlis' CEO and founder, Kasper Roet, was a featured speaker at the Innovation for Health 2025 conference held last week in Rotterdam.See details»
How Does QurAlis Work? – CANVAS, SWOT, PESTEL & BCG Matrix …
Oct 2, 2024 QurAlis is a biotechnology company that is dedicated to developing precision medicine solutions to cure ALS and FTD. By leveraging cutting-edge research and technology, …See details»
Quiver Bioscience and QurAlis Announce Research Collaboration …
39 minutes ago In addition to ALS, QurAlis is advancing a robust precision medicine pipeline to bring effective disease-modifying therapeutics to patients suffering from severe diseases …See details»
QurAlis - Golden
QurAlis is a biotechnology company developing treatments for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).See details»
QurAlis Strengthens Global Presence With Opening of European ...
Jan 3, 2024 QurAlis is currently advancing a pipeline with therapeutic candidates that target specific components of ALS pathology and defined ALS patient populations based on both …See details»
QurAlis - Contacts, Employees, Board Members, Advisors & Alumni
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.See details»
QurAlis - The Org
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root …See details»
QurAlis Company Profile - Office Locations, Competitors ... - Craft
QurAlis has 5 employees at their 1 location and $47.5 m in total funding,. See insights on QurAlis including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
QurAlis : GoodLab
QurAlis is boldly seeking to translate scientific breakthroughs into powerful precision medicines that have the potential to transform the lives of people living with neurodegenerative and …See details»
QurAlis to Present at the Stifel 2024 CNS Days - QurAlis
Mar 12, 2024 At QurAlis, we are neuro pioneers on a quest to cure. We work with a relentless pursuit of knowledge, a precise attention to craft, and an optimistic mindset to discover and …See details»
QurAlis - Work in biotech
QurAlis is using advances in precision medicine to develop therapeutics for neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative disease …See details»